Medifast Q4 revenue down 38% to $119M; EPS $0.07; guides Q1 loss

MEDIFAST INC

2024-FY EPS reported $0.19 revenue$602,463,000

Q4 revenue $119M (-37.7% YoY); active earning coaches 27,100 (-34.1% YoY).
Net income $0.8M ($0.07 diluted EPS); non-GAAP adjusted EPS $0.10.
Full year 2024 revenue $602.5M (-43.8%); net income $2.1M ($0.19 EPS).
Q1 2025 guidance: revenue $100-$120M, EPS loss $0.50 to $0.00 per share.
Cash & investments $162.3M, no debt; cites GLP-1 market headwinds.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001628280-25-006036
form_type: 8-K
ticker: MED
cik: 0000910329
company_name: MEDIFAST INC
filed_at: 2025-02-18T23:59:59+00:00
discovered_at: 2026-05-14T18:03:06.765234+00:00
generated_at: 2026-05-26T18:40:35.618971+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: negative
materiality_score: 0.85
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001628280-25-006036
json_url: https://secwatch.observer/filing/0001628280-25-006036.json
markdown_url: https://secwatch.observer/filing/0001628280-25-006036.md
text_url: https://secwatch.observer/filing/0001628280-25-006036.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/910329/000162828025006036/0001628280-25-006036-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/910329/000162828025006036/med-20250218.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001628280-25-006036

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.